Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Intrathecal Dexmedetomidine × Fentanyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Neoplasms 6 Pain 3 Burns 2 Breakthrough Pain 2 Anemia, Sickle Cell 2 Agnosia 2 Pain, Postoperative 1 Pain, Intractable 1 Lung Neoplasms 1 Intrathecal Dexmedetomidine 1 Dyspnea, Paroxysmal 1 Colonic Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1

Interventions

Fentanyl 1 Dexmedetomidine 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02861716 2018-04-10

Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery

South Egypt Cancer Institute

Phase 2 Unknown

Intrathecal Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡